About NB POSTECH
NB POSTECH is a company based in Anyang (South Korea) founded in 2008 by Joon Won Park. NB POSTECH offers products and services including BRAF V600E Detection Slide and AFM Probe. NB POSTECH operates in a competitive market with competitors including Alveo Technologies, Anavasi Diagnostics, Oxsed, Luas Diagnostics and DxLab, among others.
- Headquarter Anyang, South Korea
- Founders Joon Won Park
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website nbpostech.com
- Legal Name (주)엔비포스텍
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
- Investors
Associated legal entities of NB POSTECH
NB POSTECH operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of NB POSTECH
NB POSTECH offers a comprehensive portfolio of products and services, including BRAF V600E Detection Slide and AFM Probe.
Tool for detecting specific gene mutations in cancer diagnostics.
Probe used for atomic force microscopy in bioscience research.
Funding Insights of NB POSTECH
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of NB POSTECH with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | – | Seed | β | Gradiant | β |
1 investors in total: 1 institutional.
Investors in NB POSTECH
NB POSTECH has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gradiant.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | gradiant.co.kr | - |
Investor details for NB POSTECH
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NB POSTECH
1 people are tracked at NB POSTECH (1 in leadership).
| Name | Role | Group |
|---|---|---|
Joon Won Park | Founder & CEO | Leadership |
Complete people profiles for NB POSTECH
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NB POSTECH
2 dated milestones of NB POSTECH across 15 years, from founding to its latest funding, stage changes and deals.
- Founded NB POSTECH is founded.
- Funding First funding round.
Competitors of NB POSTECH
NB POSTECH operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alveo Technologies, Anavasi Diagnostics, Oxsed, Luas Diagnostics and DxLab, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alveotechnologies.com | 2014 | Alameda, United States | $63.61M | – | Cloud-powered POC MDx device | |
| anavasidx.com | 2020 | Seattle, United States | $6M | – | Molecular detectors for COVID-19 detection are manufactured. | |
| oxsed.com | 2020 | United Kingdom | – | 9 | Diagnostics solutions for COVID-19 infections are provided using RT-LAMP technology. | |
| luasdiagnostics.com | 2020 | Guildford, United Kingdom | $949,082 | 3 | Sensors and connected app are developed for diabetes management. | |
| dxlab.bio | 2020 | Somerville, United States | – | – | Point-of-care devices for infectious disease detection are developed. | |
| biohermes.com | 2007 | Wuxi, China | – | – | Provider of POC diagnostic devices and kits | |
| virisdetectionsystems.com | 2020 | Denver, United States | – | – | CRISPR-based RNA-guided diagnostics for SARS-CoV-2 detection are developed. |
Detailed competitors of NB POSTECH
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NB POSTECH
The website of NB POSTECH (nbpostech.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▼ 59.1% vs previous month
Latest news on Nb Postech
Complete news archive for NB POSTECH
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to NB POSTECH
10 companies that operate in the same segment as NB POSTECH (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | – | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NB POSTECH
NB POSTECH was founded in 2008 and raised its 1st funding round 15 years after it was founded.
NB POSTECH is headquartered in Anyang, South Korea. It is registered at Anyang, Gyeonggi-do, South Korea.
Joon Won Park is the current CEO of NB POSTECH. They have also founded this company.
NB POSTECH was founded in 2008 in Anyang, South Korea, within the biotechnology sector. Rapid diagnostic test kits for COVID-19 are produced through operations focused on lateral flow immunochromatographic assays. Proprietary surface coating technology is employed to detect nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal swab specimens, supporting diagnostic services in infectious disease detection.
NB POSTECH's top competitors include Alveo Technologies, DxLab and BioHermes.
NB POSTECH offers BRAF V600E Detection Slide and AFM Probe.
NB POSTECH has 1 investor. Key investors include Gradiant.
NB POSTECH operates through ,.